115 related articles for article (PubMed ID: 23746473)
21. Development of potent purine-derived nitrile inhibitors of the trypanosomal protease TbcatB.
Mallari JP; Shelat AA; Obrien T; Caffrey CR; Kosinski A; Connelly M; Harbut M; Greenbaum D; McKerrow JH; Guy RK
J Med Chem; 2008 Feb; 51(3):545-52. PubMed ID: 18173229
[TBL] [Abstract][Full Text] [Related]
22. Thiazolidinone/thiazole based hybrids - New class of antitrypanosomal agents.
Kryshchyshyn A; Kaminskyy D; Karpenko O; Gzella A; Grellier P; Lesyk R
Eur J Med Chem; 2019 Jul; 174():292-308. PubMed ID: 31051403
[TBL] [Abstract][Full Text] [Related]
23. An evaluation of Minor Groove Binders as anti-Trypanosoma brucei brucei therapeutics.
Scott FJ; Khalaf AI; Giordani F; Wong PE; Duffy S; Barrett M; Avery VM; Suckling CJ
Eur J Med Chem; 2016 Jun; 116():116-125. PubMed ID: 27060763
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agents.
Ohkanda J; Buckner FS; Lockman JW; Yokoyama K; Carrico D; Eastman R; de Luca-Fradley K; Davies W; Croft SL; Van Voorhis WC; Gelb MH; Sebti SM; Hamilton AD
J Med Chem; 2004 Jan; 47(2):432-45. PubMed ID: 14711313
[TBL] [Abstract][Full Text] [Related]
25. Novel azabicyclo[3.2.2]nonane derivatives and their activities against Plasmodium falciparum K1 and Trypanosoma brucei rhodesiense.
Berger H; Weis R; Kaiser M; Brun R; Saf R; Seebacher W
Bioorg Med Chem; 2008 Jun; 16(12):6371-8. PubMed ID: 18502136
[TBL] [Abstract][Full Text] [Related]
26. Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign.
Sykes ML; Baell JB; Kaiser M; Chatelain E; Moawad SR; Ganame D; Ioset JR; Avery VM
PLoS Negl Trop Dis; 2012; 6(11):e1896. PubMed ID: 23209849
[TBL] [Abstract][Full Text] [Related]
27. Ro 15-0216: a nitroimidazole compound active in vitro against human and animal pathogenic African trypanosomes.
Borowy NK; Nelson RT; Hirumi H; Brun R; Waithaka HK; Schwartz D; Polak A
Ann Trop Med Parasitol; 1988 Feb; 82(1):13-9. PubMed ID: 3401068
[TBL] [Abstract][Full Text] [Related]
28. Medicinal Chemistry Optimization of a Diaminopurine Chemotype: Toward a Lead for
Singh B; Diaz-Gonzalez R; Ceballos-Perez G; Rojas-Barros DI; Gunaganti N; Gillingwater K; Martinez-Martinez MS; Manzano P; Navarro M; Pollastri MP
J Med Chem; 2020 Sep; 63(17):9912-9927. PubMed ID: 32786222
[TBL] [Abstract][Full Text] [Related]
29. Cynaropicrin: the first plant natural product with in vivo activity against Trypanosoma brucei.
Zimmermann S; Kaiser M; Brun R; Hamburger M; Adams M
Planta Med; 2012 Apr; 78(6):553-6. PubMed ID: 22331812
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and antitrypanosomal activity of new 6,6,7-trisubstituted thiopyrano[2,3-d][1,3]thiazoles.
Zelisko N; Atamanyuk D; Vasylenko O; Grellier P; Lesyk R
Bioorg Med Chem Lett; 2012 Dec; 22(23):7071-4. PubMed ID: 23084895
[TBL] [Abstract][Full Text] [Related]
31. Non-natural acetogenin analogues as potent Trypanosoma brucei inhibitors.
Florence GJ; Fraser AL; Gould ER; King EF; Menzies SK; Morris JC; Tulloch LB; Smith TK
ChemMedChem; 2014 Nov; 9(11):2548-56. PubMed ID: 25145275
[TBL] [Abstract][Full Text] [Related]
32. Screening and Identification of Inhibitors of Trypanosoma brucei Cathepsin L with Antitrypanosomal Activity.
Jefferson T; McShan D; Warfield J; Ogungbe IV
Chem Biol Drug Des; 2016 Jan; 87(1):154-8. PubMed ID: 26242248
[TBL] [Abstract][Full Text] [Related]
33. SAR of 2-amino and 2,4-diamino pyrimidines with in vivo efficacy against Trypanosoma brucei.
Perales JB; Freeman J; Bacchi CJ; Bowling T; Don R; Gaukel E; Mercer L; Moore JA; Nare B; Nguyen TM; Noe RA; Randolph R; Rewerts C; Wring SA; Yarlett N; Jacobs RT
Bioorg Med Chem Lett; 2011 May; 21(10):2816-9. PubMed ID: 21507639
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and structure-activity relationship of Trypanosoma brucei leucyl-tRNA synthetase inhibitors as antitrypanosomal agents.
Ding D; Meng Q; Gao G; Zhao Y; Wang Q; Nare B; Jacobs R; Rock F; Alley MR; Plattner JJ; Chen G; Li D; Zhou H
J Med Chem; 2011 Mar; 54(5):1276-87. PubMed ID: 21322634
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo evaluation of the antitrypanosomal activity of fractions of Holarrhena africana.
Nwodo NJ; Brun R; Osadebe PO
J Ethnopharmacol; 2007 Sep; 113(3):556-9. PubMed ID: 17728085
[TBL] [Abstract][Full Text] [Related]
36. Development of Novel Isoindolone-Based Compounds against Trypanosoma brucei rhodesiense.
Silva DG; Feijens PB; Hendrickx R; Matheeussen A; Grey L; Caljon G; Maes L; Emery FS; Junker A
ChemistryOpen; 2021 Sep; 10(9):922-927. PubMed ID: 34553828
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness.
Bland ND; Wang C; Tallman C; Gustafson AE; Wang Z; Ashton TD; Ochiana SO; McAllister G; Cotter K; Fang AP; Gechijian L; Garceau N; Gangurde R; Ortenberg R; Ondrechen MJ; Campbell RK; Pollastri MP
J Med Chem; 2011 Dec; 54(23):8188-94. PubMed ID: 22023548
[TBL] [Abstract][Full Text] [Related]
38. 2,N6-disubstituted adenosine analogs with antitrypanosomal and antimalarial activities.
Rodenko B; van der Burg AM; Wanner MJ; Kaiser M; Brun R; Gould M; de Koning HP; Koomen GJ
Antimicrob Agents Chemother; 2007 Nov; 51(11):3796-802. PubMed ID: 17698622
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological activity of nitro heterocycles analogous to megazol, a trypanocidal lead.
Chauvière G; Bouteille B; Enanga B; de Albuquerque C; Croft SL; Dumas M; Périé J
J Med Chem; 2003 Jan; 46(3):427-40. PubMed ID: 12540242
[TBL] [Abstract][Full Text] [Related]
40. Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei.
Mackey ZB; Baca AM; Mallari JP; Apsel B; Shelat A; Hansell EJ; Chiang PK; Wolff B; Guy KR; Williams J; McKerrow JH
Chem Biol Drug Des; 2006 May; 67(5):355-63. PubMed ID: 16784460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
